Brainsway (BWAY) Net Cash Flow (2025 - 2026)
Brainsway posted quarterly Net Cash Flow of -$9.1 million for Q1 2026, down 495.67% year-on-year from $2.3 million in Q1 2025, and down 495.67% on a QoQ basis from $2.3 million in Q1 2025.
Brainsway (BWAY) has 2 years of Net Cash Flow data on file, last reported at -$9.1 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 495.67% year-over-year to -$9.1 million; the trailing twelve-month figure through Mar 2026 stood at -$6.8 million (down 395.67% YoY), and the FY2025 full-year result was -$1.7 million, down 102.87% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$9.1 million, down from $2.3 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $2.3 million in Q1 2025 and bottomed at -$9.1 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Brainsway | 6.80 Mn | -52.98 Mn | 11.68 Mn | -9.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.06 Mn |
| Mar 31, 2026 | -9.06 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Mar 31, 2025 | 2.29 Mn |